slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 23,581-23,610
Pages 3,683
Rows per page 30
Component
23,581-23,610 of 110,471
31
The slide uses a bulleted list to highlight key company strengths and specific clinical trial statuses for MM-120 and MM-402.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 3 hits
03
The slide highlights key operational metrics for three core business lines and displays a geographic map of US operations.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Solution3 hits
05
The slide uses a visual 'hub-and-spoke' style diagram connecting a photo of care delivery to three strategic pillars.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · ProblemLoop · Why Now3 hits
03
Nano Dimension | Results Presentation Deck | 16 slidesNano Dimension | Results Presentation Deck | 16 slides · Nano Dimension
Conference presentation Investor relations Beat · AttentionLoop · Logic Chain3 hits
05
The slide is part of a defense against Murchinson's activist campaign.Nano Dimension | Shareholder Engagement Presentation Deck | 34 slides · Nano Dimension
Shareholder letter Investor relations Beat · Interest3 hits
16
Uses a chevron-based process flow to represent chronological phases.Nano Dimension | Shareholder Engagement Presentation Deck | 34 slides · Nano Dimension
Shareholder letter Investor relations Beat · Desire3 hits
03
The slide uses a visual bracket system to connect the three pillars to the core mission statement.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 3 hits
12
The slide uses a human anatomy diagram to map specific TRK receptor inhibition side effects to body regions.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Loop · Cost Of Inaction3 hits
26
Slide 26 of a clinical presentation.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 3 hits
33
The slide outlines the key therapeutic advantages of the drug candidate NVL-330.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 3 hits
36
The slide uses a cascading hexagonal process flow to illustrate the methodology.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 3 hits
05
Includes headshots and titles for 8 executives.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations 3 hits
13
OmniAb | Investor Presentation Deck | 35 slidesOmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction3 hits
30
The slide provides a foundational understanding of how record labels operate and how they calculate profitability.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 3 hits
38
Sisecam Resources | Investor Presentation Deck | 42 slidesSisecam Resources | Investor Presentation Deck | 42 slides · Şişecam
Conference presentation Investor relations Loop · Cost Of Inaction3 hits
10
The slide uses a three-column layout to categorize the ecosystem partners.Sonos | Investor Presentation Deck | 20 slides · Sonos
Pitch deck Investor relations Beat · The Breakthrough3 hits
05
Includes non-GAAP measures disclaimer at the bottom.Sonos | Results Presentation Deck | 33 slides · Sonos
Conference presentation Investor relations 3 hits
04
The slide uses a three-column layout to categorize strategic priorities.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention3 hits
05
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Attention3 hits
22
The chart shows a significant reduction in operating expenses from 2020 to 2023.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action3 hits
33
This slide serves as a reference or bibliography page for a conference presentation.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 3 hits
35
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Loop · Before After3 hits
03
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Attention3 hits
05
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction3 hits
09
The slide details the composition of the Non-core and Legacy (NCL) perimeter, highlighting the wind-down of Credit Suisse assets.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction3 hits
03
UBS | Results Presentation Deck | 41 slidesUBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Situation & Context3 hits
04
UBS | Results Presentation Deck | 41 slidesUBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Situation & Context3 hits
08
The slide uses a process flow diagram to illustrate the methodology used for evaluating strategic options.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Before After3 hits
10
The background features a faint map of Switzerland, reinforcing the 'Swiss economy' theme.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After3 hits
12
The slide details the composition of the Non-core and Legacy (NCL) perimeter, highlighting the reduction of RWA and LRD and the strategic rationale for the exit.UBS | Results Presentation Deck | 41 slides · UBS
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After3 hits